Bloodstream infections, or central line-associated bloodstream infections, contribute to thousands of patient fatalities every year. According to a new study, many patients, especially those who are treated in community hospitals, may not be able to access effective and appropriate treatment for bloodstream infections.
The results of the study, which were published recently in the journal Plos One, found that patients who were treated at community care hospitals were less likely to receive the kind of antibiotic therapy that they needed for these infections. However, overall, the researchers found ineffective treatment not just in community care centers, but also in highly specialized hospitals, or tertiary care centers. The researchers conclude from their findings that there needs to be more improvement in the kind of treatment that a patient is given immediately after being diagnosed with a bloodstream infection at a community care center or a tertiary care center.
Part of the challenge in treating central line-associated bloodstream infections is the fact that many of these infections are now caused by superbugs, or antibiotic-resistant bacteria. An increase in the number and types of such superbugs means that many antibiotics don't work to treat the infections, and therefore, you have treatment that is ineffective.